Frontiers in Pain Research
2023
Daniella Batievsky, Michelle Weiner, Shari B Kaplan et al.
8 citations
Chronic pain and depression diagnoses are skyrocketing. There is an urgent need for more effective treatments. Ketamine was recently established to alleviate pain and depression, but many gaps remain in the scientific literature. This paper reports the findings of an observational preliminary study that explored the efficacy of ketamine-assisted psychotherapy (KAPT) for chronic pain/major...
Journal of Midwifery & Women's Health
2023
Jasmine B R Cutler, Olivia Pane, Simran K Panesar et al.
30 citations
There has been a steady increase in people with symptoms of depression over the past several years (since 2011). The further increase in stress and depression in the early part of the COVID-19 pandemic was accompanied by an increase in unmet mental health needs. Many have turned to complementary and alternative medicine (CAM) therapies such as bright-light therapy, yoga, meditation, and dietary...
Frontiers in Psychology
2023
Yuanyuan Mo, Zhiying Lei, Mei Chen et al.
5 citations
This study aimed to evaluate the effects of self-help mindfulness-based cognitive therapy (MBCT-SH) on mindfulness, symptom change, and suicidal ideation in patients with depression. For this randomized controlled study, 97 patients were randomly assigned to either the MBCT-SH (n = 48) or control (n = 49) group. The Five Facet Mindfulness Questionnaire (FFMQ), Hamilton Depression Rating Scale...
Journal of Education and Health Promotion
2023
Hassan Khazraee, Maryam Bakhtiari, Amir Sam Kianimoghadam et al.
6 citations
More than 300 million people are affected by major depressive disorder, and despite advances in treatments over the past 50 years, this number is increasing worldwide. Due to the high prevalence and increasing numbers, along with problems in various aspects of the patient's life, new effective treatments are essential in this field. This study was a single-blinded randomized clinical trial....
Progress in Brain Research
2023
Cheng-Ta Li
25 citations
Patients with major depressive disorder (MDD) often exhibit an inadequate treatment response or failure to achieve remission following treatment with antidepressant drugs. Treatment-resistant depression (TRD) is proposed to identify this clinical scenario. Compared to those without TRD, patients with TRD have significantly lower health-related quality of life in mental and physical dimensions,...
Frontiers in Psychology
2023
Yuehang Yang, Dawei Cao, Teng Lyu et al.
15 citations
Using statistical methods to analyze and summarize the research data of the inclusion criteria, to provide a quantitative average effect size to interpret the influence of mindfulness yoga exercise on patients with different depressive symptoms, explain the therapeutic effect of mindfulness yoga therapy on depression and its possible mechanism of action, and provide new ideas for the clinical...
SLEEP Advances
2023
David A Kalmbach, Philip Cheng, Anthony N Reffi et al.
16 citations
Combining mindfulness with behavioral sleep strategies has been found to alleviate symptoms of insomnia and depression during pregnancy, but mechanisms for this treatment approach remain unclear. The present study examined nocturnal cognitive arousal and sleep effort as potential treatment mechanisms for alleviating insomnia and depression via a mindfulness sleep program for pregnant women....
Frontiers in Psychiatry
2023
Linn Nyjordet Evanger, Elisabeth Flo-Groeneboom, Lin Sørensen et al.
9 citations
Embedded within a randomized efficacy trial, the present study aimed to investigate whether mindfulness-based cognitive therapy (MBCT) for recurrent depression improved symptoms of insomnia. Sixty-eight remitted participants with at least three prior episodes of depression were randomized to 8 weeks of MBCT (n = 33) or a waitlist control condition (n = 35). The Bergen Insomnia Scale was used to...
Journal of Ayurveda and Integrative Medicine
2023
53 citations
Major Depressive Disorder (MDD) is one of the leading causes of disability affecting more than 340 million people and second largest contributor to global burden of disease. Chronic stress is a common risk factor and important contributor for MDD. Stress could be defined as the "perceived inability to cope". Stressful life events are shown to provoke a sequence of psychological and...
Ibrain
2023
Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh et al.
27 citations
Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are the most common causes of emotional distress that impair an individual's quality of life. MDD is a chronic mental illness that affects 300 million people across the world. Clinical manifestations of MDD include fatigue, loss of interest in routine tasks, psychomotor agitation, impaired ability to focus, suicidal...